aid: gilgamesh-pharma
name: Gilgamesh Pharma
description: >-
  Gilgamesh Pharma (Gilgamesh Pharmaceuticals, Inc.) is a New York based clinical-stage
  neuroscience company founded in 2019 that develops rapid-acting, next-generation
  therapeutics for psychiatric and substance use disorders. Its discovery and translational
  platform combines medicinal chemistry, neurocircuitry science, electrophysiology and
  machine learning to identify new chemical entities, and its pipeline spans short-acting
  5-HT2A receptor agonists, NMDA receptor antagonists, non-hallucinogenic neuroplastogens,
  cardiac-safe ibogaine analogs and M1/M4 muscarinic programs. Lead assets include
  bretisilocin (GM-2505), acquired by AbbVie in August 2025, and blixeprodil (GM-1020), an
  orally bioavailable NMDAR antagonist in Phase 2 for major depressive disorder. Gilgamesh
  is a drug developer, not a software vendor: it publishes no developer program, public
  API, SDK or machine-readable specification of any kind.
url: https://raw.githubusercontent.com/api-evangelist/gilgamesh-pharma/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-21'
modified: '2026-08-21'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Neuroscience
- Mental Health
- Clinical Trials
- Drug Discovery
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/gilgamesh-pharma-domain-security.yml
- type: Website
  url: https://www.gilgameshpharmaceutical.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/gilgamesh-pharmaceuticals/
- type: Twitter
  url: https://twitter.com/gilgameshrx
- type: PrivacyPolicy
  url: https://mcusercontent.com/6c3f21fb747d330b7d588cc87/files/e79eefcc-bae9-6748-dc85-17d889fdb1af/Gilgamesh_Privacy_and_Expanded_Access_Policy_08.14.26.pdf
- type: Listing
  url: https://forgeglobal.com/gilgamesh-pharma_stock/
x-enrichment:
  date: '2026-08-21'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Gilgamesh Pharma is a clinical-stage drug developer whose entire web presence is a single
    static marketing page on tiiny.host; /developers, /api, /docs, /openapi.json, /graphql,
    /llms.txt and every /.well-known/ path all return the site's own 404, and the company ships
    molecules (bretisilocin, blixeprodil) rather than software, so there is no API to publish.
  evidence:
  - url: https://www.gilgameshpharmaceutical.com/
    status: 200
  - url: https://www.gilgameshpharmaceutical.com/developers
    status: 404
  - url: https://www.gilgameshpharmaceutical.com/openapi.json
    status: 404
  - url: https://www.gilgameshpharmaceutical.com/.well-known/agent-card.json
    status: 404
  checked: '2026-08-21'